llm_output,best_matching_ground_truth,best_evaluation,best_score
Selective serotonin reuptake inhibitors (SSRIs) first-line treatment Major Depressive Disorder during the acute phase,SSRIs Treat Acute phase of depression,"Score: 0.95
The LLM output is highly correct as it accurately conveys the treatment of SSRIs for Major Depressive Disorder during the acute phase, although the wording is slightly different from the ground truth.",0.95
Monoamine oxidase inhibitors (MAOIs) Less commonly used over time due to numerous side effects,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.75
The LLM output correctly acknowledges that MAOIs are less commonly used over time due to side effects, but does not address their specific efficacy in treating atypical features.",0.75
"Monoamine Oxidase Inhibitors (MAOIs) Definition the first class of antidepressants, defined by their mechanism of irreversible inhibition of the enzyme monoamine oxidase",Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.80
The LLM output provides additional information and context about monoamine oxidase inhibitors, but the overall correctness is slightly lower due to some missing details and minor inaccuracies.",0.8
Monoamine oxidase inhibitors (MAOIs) Specific efficacy in treating depression with atypical features,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output correctly identifies the use of MAOIs in pharmacotherapy but adds additional information about their specific efficacy in treating depression with atypical features, which was not explicitly mentioned in the ground truth statement.",0.75
Monoamine oxidase inhibitors (MAOIs) second-line treatment patients who have not responded to several other pharmacotherapies,Monoamine oxidase inhibitors Eligible for Patients who do not respond to other treatments,"Score: 0.85
The LLM output accurately conveys the information from the ground truth but adds slightly more detail.",0.85
Electroconvulsive therapy (ECT) Highly effective somatic therapy for depression in some specific situation,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.90
The LLM output closely reflects the ground truth but includes additional details, making it slightly more accurate.",0.9
Ketamine Highly effective for treatment-resistant depression,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.75
The LLM output is mostly correct in stating that ketamine is effective for treatment-resistant depression, but it is not as specific as the ground truth which mentions unipolar and bipolar depression as well.",0.75
Monoamine Oxidase Inhibitors (MAOIs) Less commonly used due to their complex side effects and dietary restrictions,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output correctly states that monoamine oxidase inhibitors are less commonly used due to their side effects and dietary restrictions, but does not explicitly mention that pharmacotherapy entails the use of MAOIs.",0.75
Monoamine Oxidase Inhibitors (MAOIs) Side effects hepatotoxicity and hypertensive crisis that can lead to lethal intracranial hemorrhage,Monoamine oxidase inhibitors Side effects Hepatotoxicity and hypertensive crises,"Score: 0.80
The LLM output is largely correct but provides additional information about the potential outcome of hypertensive crises that isn't explicitly mentioned in the ground truth statement.",0.8
Monoamine Oxidase Inhibitors (MAOIs) Specific efficacy in treating depression with atypical features,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.90
The LLM output is mostly correct but lacks specificity in the symptoms being treated, as it does not mention reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection.",0.9
Selective serotonin reuptake inhibitors (SSRIs) first-line treatment major depression,Depression Side effect Slower response to treatment,"Score: 0.50
The LLM output mentions the first-line treatment for major depression but does not directly address the slower response to treatment as a side effect of depression.",0.5
"Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 1.00
Both the Ground Truth and LLM Output match perfectly in terms of listing the side effects of Ketamine.",1.0
Ketamine Treats resistant unipolar and possibly bipolar depression and acute suicidal ideation,SSRIs Treat Acute phase of depression,"Score: 0.80
The LLM output is mostly correct in explaining that ketamine treats resistant unipolar and possibly bipolar depression, but it does not directly address the acute phase of depression, which is the main focus of SSRIs in the ground truth statement.",0.8
Depression Associated with high rate of suicidal behavior and mortality,Depression Side effect Suicidal behavior,"Score: 0.75
The LLM output is mostly correct as it accurately reflects the relationship between depression and suicidal behavior, but it does not explicitly mention ""side effect"" as in the ground truth.",0.75
Ketamine treats treatment-resistant depression,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.75
The LLM output is mostly correct as it mentions Ketamine treating treatment-resistant depression, which includes both unipolar and bipolar depression, but it is not as specific as the Ground Truth statement.",0.75
Monoamine oxidase inhibitors (MAOIs) specific efficacy in treating depression with atypical features,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.80
The LLM output is mostly correct as it accurately summarizes the ground truth statement, but it fails to mention specific atypical features treated by MAOIs such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection.",0.8
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment for patients with major depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output correctly identifies SSRIs as a common treatment for major depression, but it does not specifically mention it as the first-line treatment or address the acute phase of depression.",0.75
Monoamine oxidase inhibitors (MAOIs) less commonly used over time due to side effects,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output partially addresses the ground truth statement by mentioning side effects, but does not specifically mention slower response to treatment.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment major depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is mostly correct in identifying SSRIs as a common treatment for major depression, but it incorrectly states that it is the first-line treatment when in fact depression-focused psychotherapy is also a common treatment.",0.75
Esketamine (S-ketamine) approved for treatment-resistant depression by the FDA,Cognitive-behavioral therapy For Depressed patients’ with irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,"Score: 0.50

The LLM output does not directly relate to the ground truth statement, as it provides information about a specific medication for treatment-resistant depression rather than cognitive-behavioral therapy for depressed patients with irrational beliefs and distorted cognitions.",0.5
"Selective Serotonin Reuptake Inhibitors (SSRIs) Side effects sexual and digestive (nausea and loss of appetite), as well as irritability, anxiety, insomnia, and headache",Pharmacotherapy Entails Norepinephrine reuptake inhibitors,"Score: 0.75
The LLM output provides relevant information on SSRIs and their side effects, but the statement does not align with the ground truth regarding norepinephrine reuptake inhibitors.",0.75
Bupropion side effects more likely than some SSRIs to lead to minimal weight gain or even weight loss,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.75
The LLM output mentions a relevant fact about bupropion compared to some SSRIs, but does not directly address the ground truth statement about norepinephrine reuptake inhibitors being eligible for patients who do not respond to SSRIs.",0.75
Treatment during the acute phase of a major depressive episode Goal help the patient reach a remission state and eventually return to their baseline level of functioning,Electroconvulsive therapy Goal Lighten the burden of depression,"Score: 0.80
The LLM output captures the essence of the ground truth statement by focusing on treating depression and helping the patient achieve remission and return to their baseline level of functioning, but it lacks the direct mention of electroconvulsive therapy.",0.8
Physical Exercise recommended adjunct to other anti-depressive treatment,Physical Exercise Finding an adjunct to other Anti-depressive treatments,"Score: 0.95
The LLM output is almost identical to the ground truth, only missing the word ""finding"" and changing ""recommended"" to ""recommending.""",0.95
Esketamine approved for treatment-resistant depression,"Deep Brain Stimulation Findings Elicited a clinical response in 60% of resistant depression patients after six months and clinical remission in 35% of patients, with benefits maintained for over 12 mo","Score: 0.50
The LLM output is only partially correct as it mentions esketamine for treatment-resistant depression, but does not provide the same level of detail as the ground truth statement about Deep Brain Stimulation findings.",0.5
Cognitive-behavioral therapy (CBT) widely used for treating major depressive disorder,"Depression-focused psychotherapy Entails Cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), Supportive therapy (ST) and psychoeducational intervention (PEI)","Score: 0.75
The LLM output is mostly correct, mentioning CBT as a key therapy for depression, but it lacks specificity by not including other common therapies like IPT, ST, and PEI.",0.75
"Ketamine side effects neurotoxicity, cognitive dysfunction, and potential for drug abuse","Ketamine Has effects on Unipolar, bipolar depression","Score: 0.50
The LLM output is only partially correct as it focuses on the side effects and potential risks of ketamine, but does not mention its known effects on unipolar and bipolar depression.",0.5
Tricyclic antidepressants (TCAs) more effective than SSRIs in treating hospitalized patients with severe major depressive disorder,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.75
The LLM output is somewhat correct as it mentions the superiority of TCAs over SSRIs in treating severe major depressive disorder, but it incorrectly identifies the drug class compared to bupropion.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment Major Depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is mostly correct in identifying SSRIs as a first-line treatment for Major Depression, but it incorrectly labels it as the most common treatment in the acute phase.",0.75
Cognitive Behavioral Therapy (CBT) first-line treatment mild to moderate major depressive disorder,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.90
The LLM output is very close to the ground truth statement, with only slight differences in wording.",0.9
"Ketamine associated with short antidepressant effect, possible neurotoxicity, and drug dependence","Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 0.50
The LLM Output is only partially correct as it mentions some side effects and potential benefits of ketamine, but misses several other important side effects listed in the ground truth.",0.5
Ketamine Treats Treatment-resistant Major Depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM Output correctly mentions a specific pharmacotherapy (Ketamine) for the treatment of major depression, but does not fully match the Ground Truth as it specifies treatment-resistant major depression instead of simply acute phase of depression.",0.75
Monoamine Oxidase Inhibitors (MAOIs) Less commonly used Major Depression,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output is mostly correct, but it lacks the specificity of specifying that pharmacotherapy entails monoamine oxidase inhibitors.",0.75
Electroconvulsive therapy (ECT) Highly effective All Depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.75
The LLM output is mostly correct but oversimplifies the effectiveness of electroconvulsive therapy by stating it is effective for all types of depression.",0.75
Interpersonal Therapy (IPT) first-line treatment mild to moderate major depressive episode in adults,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.75
The LLM output is not highly correct as it incorrectly suggests Interpersonal Therapy (IPT) as the first-line treatment for atypical features in depression, when in fact Monoamine oxidase inhibitors have demonstrated specific efficacy.",0.75
Bupropion Side effects Minimal weight gain or even weight loss,"Bupropion Properties A better tolerability than SSRIs, with minimal weight gain","Score: 0.75
The LLM output is mostly correct as it mentions minimal weight gain or even weight loss associated with bupropion, which aligns with the ground truth statement. However, it does not specifically mention better tolerability compared to SSRIs.",0.75
Therapeutic Monitoring of Ketamine Treatment lacks guidelines for depression,"Psycho-education Goal Addresses Issues such as misperceptions about medication, treatment duration, the risk of relapse, and prodromes of depression","Score: 0.75
The LLM output is partially correct as it mentions the lack of guidelines for depression treatment, but it doesn't address all the issues mentioned in the ground truth statement about psycho-education goals.",0.75
Cognitive Behavioral Analysis System of Psychotherapy (CBASP) recommended for chronic depression,Electroconvulsive therapy Goal Lighten the burden of depression,"Score: 0.75
The LLM Output is somewhat relevant as it mentions a psychotherapy recommended for chronic depression, but it does not directly relate to electroconvulsive therapy mentioned in the Ground Truth.",0.75
Psychotherapy Treats Mild to moderate Major Depression,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.75
The LLM output is mostly correct in conveying the information from the ground truth, but it lacks specificity in mentioning that the psychotherapy is depression-focused.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment major depression,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.75
The LLM output partially addresses the ground truth by mentioning SSRIs as a first-line treatment for major depression, but it does not specifically mention the eligibility of Norepinephrine reuptake inhibitors for patients who do not respond to SSRIs.",0.75
Cognitive-Behavioral Therapy (CBT) first-line treatment Major Depression,"Depression-focused psychotherapy Entails Cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), Supportive therapy (ST) and psychoeducational intervention (PEI)","Score: 0.75
The LLM output correctly identifies CBT as a first-line treatment for major depression, but it does not provide a comprehensive list of all the depression-focused psychotherapies mentioned in the ground truth.",0.75
Monoamine Oxidase Inhibitors (MAOIs) less commonly used due to their irreversible inhibition of monoamine oxidase and numerous side effects,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.80
The LLM output correctly identifies an outdated treatment option (MAOIs) and explains why they are less commonly used, but does not address the wider range of acute-phase treatment options for depression.",0.8
Physical exercise Associated with Improvement in quality of life for depression patients,Physical Exercise Benefits Improvements in one’s quality of life,"Score: 0.75
The LLM output is somewhat correct but not entirely accurate as it specifically mentions improvement in quality of life for depression patients, whereas the ground truth statement is more general and does not specify a particular group.",0.75
"Bupropion side effects minimal weight gain or even weight loss, more likely to improve symptoms of fatigue and sleepiness than some SSRIs",SSRIs Treat Acute phase of depression,"Score: 0.75
The LLM output talks about bupropion and its side effects and benefits compared to SSRIs, which is somewhat related to treating depression but doesn't directly address the statement about SSRIs treating the acute phase of depression.",0.75
Repetitive Transcranial Magnetic Stimulation (rTMS) More effective Depression with mild side effects,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.80
The LLM output captures the main idea of the ground truth statement but lacks the specific comparison between rTMS and antidepressants in terms of effectiveness.",0.8
Mindfulness-Based Cognitive Therapy (MBCT) Benefits High risk of depressive relapse,Cognitive-behavioral therapy For Depressed patients’ with irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,"Score: 0.75
The LLM output is somewhat related to the ground truth but does not fully capture the focus on challenging and reversing irrational beliefs and distorted cognitions to treat depression.",0.75
Tricyclic Antidepressants (TCAs) Comparable to SSRIs and MAOIs in treating major depression,Nefazodone Is comparable to SSRI,"Score: 0.75
The LLM output is mostly correct in mentioning TCAs as being comparable to SSRIs in treating major depression, but it also includes MAOIs which is not mentioned in the ground truth.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment Major Depression,Depression Side effect Slower response to treatment,"Score: 0.50
The LLM output is partially correct as it mentions Selective Serotonin Reuptake Inhibitors (SSRIs) as a first-line treatment for Major Depression, but does not mention the slower response to treatment as a side effect of depression.",0.5
Cognitive-Behavioral Therapy (CBT) first-line treatment mild to moderate major depressive disorder,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.90
The LLM output is highly correct but lacks the specific mention of ""depression-focused psychotherapy"" in the ground truth.",0.9
Electroconvulsive therapy (ECT) Highly effective major unipolar depression,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output correctly identifies ECT as a somatic therapy option for depression, but lacks completeness by not mentioning other acute-phase treatment options.",0.75
Electroconvulsive Therapy (ECT) most effective somatic therapy for resistant forms of depression in specific situations,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.80
The LLM output adds specificity and nuance to the ground truth statement, making it more accurate overall.",0.8
"Monoamine Oxidase Inhibitors (MAOIs) less commonly used due to irreversible inhibition of monoamine oxidase, numerous side effects such as hepatotoxicity and hypertensive crisis",Monoamine oxidase inhibitors Side effects Hepatotoxicity and hypertensive crises,"Score: 0.90
The LLM output is mostly correct in summarizing the ground truth statement but adds extra information about why MAOIs are less commonly used.",0.9
Ketamine highly effective in intravenous sub-anesthetic dose for resistant unipolar and possibly bipolar depression and acute suicidal ideation,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.90
The LLM output is highly correct as it accurately summarizes the effects of Ketamine on unipolar and bipolar depression, along with acute suicidal ideation.",0.9
Mindfulness-Based Cognitive Therapy (MBCT) Treats preventing depressive relapse,"Mindfulness-based cognitive therapy Goal Reduce, or even stop, antidepressant treatment without increasing the risk of depressive recurrence, especially for patients at a high risk of relapse","Score: 0.90
The LLM output is mostly correct in summarizing the goal of mindfulness-based cognitive therapy as preventing depressive relapse, but misses the important aspect of reducing or stopping antidepressant treatment.",0.9
Interpersonal Therapy (IPT) first-line treatment mild to moderate major depressive episodes in adults,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.80
The LLM Output is mostly correct in identifying Interpersonal Therapy (IPT) as a first-line treatment for mild to moderate major depressive episodes in adults, but it slightly mislabels the severity of the condition as Mild to moderate MDD instead of major depressive episodes.",0.8
Cognitive Behavioral Therapy (CBT) first-line treatment mild to moderate Major Depressive Disorder,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.80
The LLM output is mostly correct but with some discrepancies in terminology and structure compared to the ground truth.",0.8
Ketamine Results rapid effect on resistant depression and acute suicidal ideation,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is generally correct in linking ketamine with rapid treatment effects for resistant depression and acute suicidal ideation, but it does not specifically mention pharmacotherapy as a broad treatment option for the acute phase of depression.",0.75
Physical exercise associated with improvements in quality of life and adjunct to other antidepressant treatment for depression,Physical Exercise Finding an adjunct to other Anti-depressive treatments,"Score: 0.85
LLM Output is mostly correct but includes ""quality of life"" which is not explicitly mentioned in the Ground Truth statement.",0.85
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment Major Depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output correctly identifies SSRIs as a first-line treatment for Major Depression but incorrectly states it as the second most common treatment for Acute phase depression.",0.75
Electroconvulsive therapy (ECT) Highly effective Major unipolar depression,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output accurately mentions electroconvulsive therapy as a treatment option for major unipolar depression, but it is not the only treatment option mentioned in the ground truth statement.",0.75
Regular physical activity Associated with alleviation of depressive symptoms and prevention of relapse,Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.75
The LLM output is mostly correct in discussing the benefits of regular physical activity in alleviating depressive symptoms and preventing relapse, but it does not directly address the comparison in the Ground Truth statement regarding Bupropion and SSRIs.",0.75
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) second-line treatment patients who do not respond to SSRIs,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output partially captures the idea of slower response to treatment in depression by mentioning SNRIs as a second-line treatment for patients who do not respond to SSRIs, but it does not directly address the concept of slower response.",0.75
Repetitive Transcranial Magnetic Stimulation (rTMS) Widely used depression research,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output covers the main somatic treatment method, rTMS, but lacks detail on the other treatments mentioned in the ground truth.",0.75
"Psycho-education Benefits improved clinical course, treatment adherence, and psychosocial function in patients with depression",Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.80
The LLM output is somewhat related to the ground truth as both statements discuss benefits of psychotherapy in treating different mental health conditions, but the LLM output does not accurately match the ground truth statement.",0.8
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment major depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is mostly correct in identifying SSRIs as a first-line treatment for major depression, but it inaccurately states that it is the most common treatment when it is actually the second most common treatment.",0.75
Interpersonal Therapy (IPT) first-line treatment mild to moderate major depressive episode in adults,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.75
The LLM output is relevant to depression treatment but lacks specificity in comparison to the ground truth statement.",0.75
Monoamine Oxidase Inhibitors (MAOIs) Less commonly used due to their irreversible inhibition of monoamine oxidase and numerous side effects,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.80
The LLM output correctly expands on the ground truth statement by providing additional information about MAOIs, such as their mode of action and common side effects, but does not contradict the original statement.",0.8
Monoamine Oxidase Inhibitors (MAOIs) Less commonly used over time due to side effects,Monoamine oxidase inhibitors Side effects Hepatotoxicity and hypertensive crises,"Score: 0.75
The LLM output is somewhat correct as it mentions the side effects of MAOIs, but it doesn't specifically mention hepatotoxicity and hypertensive crises.",0.75
Repetitive Transcranial Magnetic Stimulation (RTMS) More effective when combined with antidepressants than placebo conditions with mild side effects and good acceptability,"Bupropion Properties A better tolerability than SSRIs, with minimal weight gain","Score: 0.75
The LLM output is slightly relevant as it discusses treatment options for depression, but lacks direct connection to the ground truth statement about bupropion properties.",0.75
"Ketamine side effects dizziness, neurotoxicity, cognitive dysfunction, psychosis, dissociation","Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 0.75
The LLM output is missing some side effects listed in the ground truth, but it still captures some key side effects accurately.",0.75
Vagus Nerve Stimulation (VNS) treats resistant unilateral or bipolar depression,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.75
The LLM output is largely correct in mentioning a treatment for depression, but it is not directly comparable to the ground truth, which refers to marital and family therapy for severe forms of depression associated with medications and hospitalization.",0.75
Monoamine Oxidase Inhibitors (MAOIs) less commonly used due to irreversible inhibition causing numerous side effects,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output correctly acknowledges that Monoamine Oxidase Inhibitors (MAOIs) are less commonly used due to their irreversible inhibition and side effects, but it does not directly reflect the ground truth statement about pharmacotherapy involving MAOIs.",0.75
"Escitalopram More effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.60
The LLM output partially matches the ground truth by mentioning fluoxetine, fluvoxamine, and paroxetine, but also includes duloxetine and reboxetine which are not part of the SSRI class.",0.6
"Mirtazapine More effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Mirtazapine As effective as SSRIs,"Score: 0.75
The LLM output is mostly correct in stating that Mirtazapine is more effective than specific SSRIs, but it is missing the comparison to SSRIs as a whole, leading to a slightly lower score.",0.75
"Venlafaxine More effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.50
The LLM output mentions specific antidepressants, while the ground truth statement talks about the overall effectiveness of rTMS and antidepressants, leading to a moderate correctness score.",0.5
"Sertraline More effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.75
The LLM output lists some SSRIs correctly but also includes duloxetine and reboxetine, which are not SSRIs.",0.75
Reboxetine Less effective all other tested antidepressants,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies that reboxetine is less effective than other tested antidepressants, but does not mention the comparison to repetitive transcranial magnetic stimulation (rTMS) as seen in the ground truth.",0.75
Escitalopram first-line treatment major depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is mostly incorrect as it incorrectly mentions Escitalopram as the first-line treatment for major depression, while the ground truth specifies depression-focused psychotherapy as the second most common treatment for Acute phase depression.",0.75
Sertraline first-line treatment major depression,Depression Side effect Slower response to treatment,"Score: 0.50
The output partially addresses the concept of depression treatment, but does not mention the slower response to treatment side effect.",0.5
"Selective Serotonin Reuptake Inhibitors (SSRIs) side effects sexual and digestive issues, irritability, anxiety, insomnia, and headache","Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.50
The LLM output incorrectly attributes side effects of SSRIs to monoamine oxidase inhibitors, leading to a lower correctness score.",0.5
venlafaxine Comparable to tricyclic antidepressants (TCAs),Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.75
The LLM output is mostly correct as it states that venlafaxine is comparable to tricyclic antidepressants, which is similar to the ground truth statement that monoamine oxidase inhibitors have the same efficacy as tricyclic antidepressants.",0.75
reboxetine Less effective all the other antidepressants tested,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output is mostly correct in stating that reboxetine is less effective than other antidepressants, but it incorrectly implies that it was compared to all antidepressants when it was actually compared to rTMS in the ground truth statement.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment Major Depressive Disorder,Pharmacotherapy Entails Norepinephrine reuptake inhibitors,"Score: 0.50
The LLM output is not highly correct as it inaccurately mentions SSRIs instead of Norepinephrine reuptake inhibitors in the context of pharmacotherapy.",0.5
escitalopram and sertraline More effective other second-generation antidepressants,Transcranial direct current stimulation Results Lower than that of antidepressants and rTMS,"Score: 0.75
The LLM output is partially correct as it mentions the efficacy of certain antidepressants, but it does not directly address the comparison made in the ground truth statement.",0.75
Repetitive Transcranial Magnetic Stimulation (rTMS) treats depression with improvement in symptoms,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output is mostly correct as it mentions rTMS as a treatment for depression, but it does not provide a complete list of somatic treatments or specify that the improvement in symptoms is associated with treating depression.",0.75
"escitalopram and sertraline side effects fewer discontinuations than duloxetine, fluvoxamine, paroxetine, reboxetine, and venlafaxine",Duloxetine Side effects Lower acceptability,"Score: 0.75
The LLM output covers more medications and compares side effects leading to discontinuations, but it does not directly address the statement regarding duloxetine's lower acceptability.",0.75
Cognitive Behavioral Therapy (CBT) Overview targets depressed patients' irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,Cognitive-behavioral therapy For Depressed patients’ with irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,"Score: 0.95
The LLM output captures the main idea of the ground truth but slightly rephrases it.",0.95
Electroconvulsive Therapy (ECT) highly effective severe and psychotic depression,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.75
The LLM output is partially correct as Electroconvulsive Therapy (ECT) can be effective for severe depression, however, it does not address the specific treatment of severe forms of depression associated with medications and hospitalization as stated in the ground truth.",0.75
bupropion side effects minimal weight gain or even weight loss,"Bupropion Properties A better tolerability than SSRIs, with minimal weight gain","Score: 0.80
The LLM output captures the main point that bupropion is associated with minimal weight gain or even weight loss, but does not mention its better tolerability than SSRIs.",0.8
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment major depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output correctly identifies SSRIs as a first-line treatment for major depression, but incorrectly states it as the second most common treatment for acute phase depression.",0.75
reboxetine less effective than all other tested antidepressants,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output is mostly correct but lacks some context from the ground truth statement.",0.75
"escitalopram more effective than duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.75
The LLM output is mostly correct in listing the SSRIs and stating that escitalopram is more effective than the other medications mentioned, but it inaccurately includes duloxetine and reboxetine, which are not SSRIs.",0.75
Electroconvulsive therapy (ECT) Highly effective major unipolar depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.75
The LLM output is mostly correct but simplifies the concept by not including the nuance that ECT is effective in some situations and during the acute phase of depression.",0.75
"escitalopram more tolerable than duloxetine, fluvoxamine, paroxetine, reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.75
The LLM output is mostly correct but misses mentioning fluoxetine, sertraline, and citalopram as part of the SSRIs while comparing the tolerability of different antidepressants.",0.75
"sertraline more tolerable than duloxetine, fluvoxamine, paroxetine, reboxetine",Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.50
The LLM output is not directly related to the ground truth statement and does not show a clear comparison between bupropion and SSRIs.",0.5
"ketamine side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 1.00
The LLM output is identical to the ground truth statement, resulting in a perfect score for overall correctness.",1.0
"Escitalopram More effective Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.70
The LLM output correctly identified specific antidepressants, but did not mention repetitive Transcranial Magnetic Stimulation (rTMS) as being more effective, resulting in a slightly lower score for overall correctness.",0.7
"Sertraline More effective Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.50
The LLM output contains some correct information (mentioning sertraline), but also includes inaccuracies and is not comprehensive.",0.5
sertraline More commonly used treatment for moderate to severe major depression in adults,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is mostly correct, but it incorrectly states the medication as the ""second most common treatment"" when it is actually the most common treatment for moderate to severe major depression in adults.",0.75
"Mirtazapine More effective Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Mirtazapine As effective as SSRIs,"Score: 0.75
The LLM output is mostly correct in stating that Mirtazapine is more effective than certain SSRIs, but it incorrectly includes Duloxetine and Reboxetine, which are not SSRIs.",0.75
Reboxetine Less effective all other 11 antidepressants,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output contradicts the ground truth as it states that reboxetine is less effective than all other 11 antidepressants, while the ground truth states that rTMS and antidepressants are more effective.",0.75
"Venlafaxine More effective Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies various antidepressants, but does not specifically mention repetitive Transcranial Magnetic Stimulation (rTMS) as being more effective.",0.75
"Major Depressive Disorder Treats Escitalopram, Sertraline, Mirtazapine, Venlafaxine",Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.50
The LLM output is not highly correct as it incorrectly associates treatments with disorders.",0.5
Interpersonal Therapy (IPT) first-line treatment mild to moderate major depressive episodes in adults and well-established intervention for adolescents with depression,Monoamine oxidase inhibitors Eligible for Patients who do not respond to other treatments,"Score: 0.75
The LLM output is partially correct as it mentions a first-line treatment for major depressive episodes but does not accurately reflect the ground truth regarding monoamine oxidase inhibitors.",0.75
Physical Exercise definition recommended non-pharmacological treatment to alleviate symptoms and prevent relapse of depression,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output describes a recommended non-pharmacological treatment for depression, which partially aligns with the ground truth of slower response to treatment in depression, but does not directly address the side effect aspect.",0.75
Electroconvulsive therapy (ECT) treats major unipolar depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.75
The LLM output is mostly correct but oversimplifies the effectiveness of Electroconvulsive therapy for depression by focusing only on major unipolar depression.",0.75
Mirtazapine highly effective Major Depressive Disorder,Mirtazapine As effective as SSRIs,"Score: 0.75
The LLM output is mostly correct in terms of the effectiveness of Mirtazapine for Major Depressive Disorder, but the comparison to SSRIs is not included.",0.75
Escitalopram More commonly used treatment of major depression due to better acceptability and fewer discontinuations,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is mostly relevant and accurate regarding the treatment of major depression but does not directly address the slower response to treatment as a side effect of depression.",0.75
Reboxetine less effective all other 11 antidepressants for treating major depression,Monoamine oxidase inhibitors Eligible for Patients who do not respond to other treatments,"Score: 0.75
The LLM output is mostly correct in stating that reboxetine is less effective than other antidepressants, but it does not directly correlate with the ground truth statement about monoamine oxidase inhibitors being eligible for patients who do not respond to other treatments.",0.75
Sertraline More commonly used treatment of major depression due to better acceptability and fewer discontinuations,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output provides additional information about the specific drug sertraline but still aligns with the ground truth that pharmacotherapy treats acute phase of depression.",0.75
"Antidepressants (e.g., sertraline, escitalopram) treats Major Depressive Disorder",Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.25
The LLM output is largely incorrect as it discusses antidepressants for Major Depressive Disorder, while the ground truth is about Schema Therapy for personality disorder comorbidity.",0.25
Escitalopram first-line treatment adults with moderate to severe major depression,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.50
The LLM output is partially correct by mentioning escitalopram as a first-line treatment for moderate to severe major depression, but it does not fully capture the comparison with bupropion and the specific population (patients with MDD).",0.5
Sertraline first-line treatment adults with moderate to severe major depression,"Depression-focused psychotherapy Goal To monitor their mood, improve their functioning, understand their symptoms better, and master the practical tools they need to cope with stressful events","Score: 0.75
The LLM output is somewhat relevant as it mentions a common medication used to treat depression, but it does not fully capture the comprehensive approach and goals of depression-focused psychotherapy described in the ground truth.",0.75
Sertraline first-line treatment moderate to severe major depression in adults,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.75
The LLM output is mostly correct in mentioning sertraline as a first-line treatment for moderate to severe major depression in adults, but it does not directly address the comparison made in the ground truth statement regarding the activating profile of bupropion compared to SSRIs.",0.75
Escitalopram first-line treatment moderate to severe major depression in adults,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.75
The LLM output is mostly correct, but there is a slight deviation in severity level and specific treatment method compared to the ground truth.",0.75
"Escitalopram More effective Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.50
The LLM output correctly identifies escitalopram as part of the SSRI class of medications but incorrectly lists duloxetine and reboxetine as SSRIs, leading to a lower overall correctness score.",0.5
Escitalopram highly effective moderate to severe major depression in adults,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.75
The LLM output is somewhat related to the ground truth in terms of effectiveness for depression, but it focuses on a specific medication (Escitalopram) and severity level (moderate to severe major depression) while omitting any mention of electroconvulsive therapy.",0.75
"Selective Serotonin Reuptake Inhibitors (SSRIs) side effects sexual and digestive (nausea and loss of appetite), as well as irritability, anxiety, insomnia, and headache",Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.75
The LLM output correctly mentions the side effects of SSRIs but does not directly address the comparison with Bupropion in terms of improving symptoms of fatigue and sleepiness.",0.75
"Bupropion, Citalopram Well tolerated Duloxetine, Fluvoxamine, Paroxetine, Reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.30
The LLM output contains some correct medications but also includes bupropion and duloxetine which are not part of the SSRI group.",0.3
"Sertraline More effective Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.50
The LLM output missed some medications and included ones not in the ground truth, leading to a lower correctness score.",0.5
"Venlafaxine More effective Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies various antidepressants as potentially more effective than each other, but does not specifically mention repetitive Transcranial Magnetic Stimulation (rTMS).",0.75
"Antidepressants (e.g., bupropion, citalopram, escitalopram, sertraline) side effects varies based on the medication",Fluoxetine Side effects Generally acceptable side effect profile,"Score: 0.75
The LLM output mentions various antidepressants and their side effects, which is relevant but not fully accurate in comparison to the ground truth which specifically mentions fluoxetine and its generally acceptable side effect profile.",0.75
"Mirtazapine More effective Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Mirtazapine As effective as SSRIs,"Score: 0.75
The LLM output correctly expands on the ground truth by stating that Mirtazapine is more effective than certain SSRIs, but it is not as specific as the ground truth.",0.75
Citalopram first-line treatment major depressive disorder,"Mindfulness-based cognitive therapy Goal Reduce, or even stop, antidepressant treatment without increasing the risk of depressive recurrence, especially for patients at a high risk of relapse","Score: 0.50
The LLM output is not very correct as it does not directly address the goal of mindfulness-based cognitive therapy, which is to reduce or stop antidepressant treatment without increasing the risk of depressive recurrence.",0.5
Citalopram Treats major depressive disorder in adults,Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.50
The LLM output is partially correct as it mentions a treatment for a specific disorder, but it is not directly related to the ground truth, which is about Schema Therapy for personality disorder comorbidity.",0.5
Anxious depression More common than nonanxious depression,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.50
The first statement is unrelated to the second statement, so they cannot be directly compared for correctness.",0.5
Anxious depression More common than nonanxious depression,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.50
The LLM output is unrelated to the ground truth statement, so it receives a low correctness score.",0.5
Reboxetine less commonly used due to being less efficacious and less tolerable compared to other antidepressants,Transcranial direct current stimulation Results Lower than that of antidepressants and rTMS,"Score: 0.80
The LLM output is mostly correct in terms of comparing the efficacy and tolerability of Reboxetine to other antidepressants, but there is a slight misalignment in the comparison to transcranial direct current stimulation and rTMS as mentioned in the ground truth.",0.8
Reboxetine not effective as a routine first-line acute treatment for major depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.80
The LLM output provides a specific and accurate assessment of the effectiveness of reboxetine in treating major depression, but does not directly contradict the ground truth statement.",0.8
Anxious depression More effective than nonanxious depression,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.50
The LLM output is partially correct in recognizing that bupropion is more effective for anxious depression, but it fails to mention its activating profile and comparison to SSRIs.",0.5
Anxious depression Less effective citalopram treatment in achieving remission compared to nonanxious depression,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output captures the general idea of depression having a slower response to treatment, but it focuses on anxious depression specifically and a specific medication, which may not apply to all cases of depression and treatment options.",0.75
Citalopram first-line treatment nonpsychotic major depressive disorder,"Mindfulness-based cognitive therapy Goal Reduce, or even stop, antidepressant treatment without increasing the risk of depressive recurrence, especially for patients at a high risk of relapse","Score: 0.25
The LLM output is not highly correct as it does not accurately reflect the goal of mindfulness-based cognitive therapy for reducing or stopping antidepressant treatment for patients at high risk of relapse.",0.25
Anxious depression More common than nonanxious depression,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.75
The LLM output is somewhat related to the ground truth, as both statements involve characteristics of depression, but the LLM output does not directly address the comparison of bupropion and SSRIs.",0.75
"Antidepressants (e.g., escitalopram, sertraline) more commonly used for their favorable balance between efficacy and acceptability in treating Major Depressive Disorder",Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.75
The LLM output is mostly correct as it accurately mentions the use of antidepressants in treating Major Depressive Disorder, but it misses the specific comparison of bupropion and SSRIs in terms of activation and efficacy.",0.75
Citalopram first-line treatment major depressive disorder in STAR*D Level 1,"Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.50
The LLM output is only partially correct as it mentions Citalopram as a first-line treatment for major depressive disorder, but it is not entirely relevant to the ground truth of problem-solving therapy for preventing depression in the elderly or treating mild depressive symptoms.",0.5
All Depression Treats Cognitive Behavioral Therapy (CBT),Pharmacotherapy Treats Acute phase of depression,"Score: 0.50
The LLM output is only partially correct as it incorrectly states that all depression is treated with Cognitive Behavioral Therapy (CBT), which is not accurate.",0.5
Anxious depression Associated with significant clinical and sociodemographic differences from those without anxious depression,Cognitive-behavioral therapy For Depressed patients’ with irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,"Score: 0.50
The LLM output is not addressing the same topic as the ground truth statement, so it receives a lower score for overall correctness.",0.5
Anxious depression More common than nonanxious depression,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.50
The LLM output is not related to the ground truth statement, resulting in a low correctness score.",0.5
Anxious depression Symptom major depressive disorder with high levels of anxiety symptoms,Interpersonal Therapy Goal Identify triggers of depression episodes,"Score: 0.75
The LLM output is mostly correct in identifying symptoms related to depression with anxiety, but it does not explicitly mention the goal of identifying triggers.",0.75
Anxious depression Definition major depressive disorder with a baseline HAMD anxiety/somatization factor score of 7 or higher,Interpersonal Therapy Goal Identify triggers of depression episodes,"Score: 0.75
The LLM Output is somewhat related to the Ground Truth, as it mentions major depressive disorder and anxiety, but it does not specifically address the goal of identifying triggers of depression episodes.",0.75
Citalopram first-line treatment major depressive disorder in STAR*D study,"Mindfulness-based cognitive therapy Goal Reduce, or even stop, antidepressant treatment without increasing the risk of depressive recurrence, especially for patients at a high risk of relapse","Score: 0.50
The LLM output is not directly related to the ground truth statement and does not address the goal of reducing antidepressant treatment while preventing depressive recurrence.",0.5
Anxious depression Associated with lower remission rates compared to nonanxious depression following antidepressant treatment,Depression Side effect Slower response to treatment,"Score: 0.80
The LLM output is mostly correct as it discusses the association between anxiety and lower remission rates in depression treatment, but it does not specifically mention slower response to treatment as in the ground truth statement.",0.8
Anxious depression More common than nonanxious depression,Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.50
The LLM output is somewhat relevant but not directly answering the comparison between the two statements.",0.5
"Anxious depression Associated with higher rates of suicidality, unemployment, less education, public insurance, and lower income","Interpersonal Therapy Goal Resolves Mourning, recognition of patient’s own affect, resolving social interaction dysfunction, building social skills and social support","Score: 0.75
The LLM output is somewhat relevant but not directly related to the Ground Truth as it discusses factors associated with anxious depression rather than goals of interpersonal therapy.",0.75
"Anxious depression Associated with higher rates of severity, illness chronicity, functional impairment, and risk of suicidality",Transcranial direct current stimulation Results Outperforms the simulator by rate of response and remission,"Score: 0.75
The overall correctness score is lower because the LLM output is not directly related to the ground truth statement, but it still provides relevant information about anxious depression.",0.75
Anxious depression Less effective treatment with citalopram than nonanxious depression,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output captures the general idea of slower response to treatment in depression, but focuses specifically on treatment with citalopram and mentions anxiety, which is not explicitly in the ground truth statement.",0.75
Anxious depression Associated with poor acute outcome than nonanxious depression following antidepressant treatment,"Deep Brain Stimulation Findings Elicited a clinical response in 60% of resistant depression patients after six months and clinical remission in 35% of patients, with benefits maintained for over 12 mo","Score: 0.75
The LLM output is somewhat related to the ground truth as both statements discuss depression outcomes, but the LLM output is not as accurate or specific as the ground truth.",0.75
Citalopram Treats major depressive disorder but with differentiated effectiveness in anxious vs nonanxious depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is mostly correct in mentioning citalopram as a treatment for major depressive disorder, but introduces unnecessary complexity with the differentiation between anxious and nonanxious depression.",0.75
Citalopram first-line treatment Major depressive disorder in the STAR*D Level 1 treatment,Cognitive-behavioral therapy Use For the first time treatment,"Score: 0.75
The LLM output is somewhat relevant to the ground truth, but the medications mentioned are not consistent with cognitive-behavioral therapy.",0.75
"Anxious depression Associated with Greater severity of depression, more concurrent anxiety disorder, more melancholic/endogenous feature, unemployment, less education, marital status (divorced/widowed), public insurance, lower income",Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.75
The LLM output is somewhat relevant to the ground truth as it discusses aspects of depression and associated factors, but it does not directly address the comparison of bupropion and SSRIs.",0.75
Sertraline Recommended as a first choice for the treatment of moderate to severe major depression,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.80
The LLM output is mostly correct but misses the mention of other treatment options listed in the ground truth.",0.8
Anxious depression Less effective citalopram treatment compared to those with nonanxious depression,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output correctly identifies a relationship between depression and treatment effectiveness, but it misinterprets the type of depression and the specific medication mentioned in the ground truth.",0.75
"Anxious depression Associated with unemployment, low education, public insurance, lower income, severe depression, greater perceived physical impairment, diminished quality of life, later onset of major depression, more concurrent anxiety disorders, more melancholic/endogenous features, more medical comorbidity",Interpersonal Therapy Goal Identify triggers of depression episodes,"Score: 0.75
The LLM output provides information related to factors associated with anxious depression, which may be relevant in identifying triggers of depression episodes, but does not directly address the goal of identifying triggers.",0.75
Anxious depression Benefits Anxious depression taking longer to remit with treatment than nonanxious depression,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output correctly conveys the idea that anxious depression may take longer to improve with treatment compared to nonanxious depression; however, the use of the term ""benefits"" is not appropriate in this context.",0.75
"Anxious depression Associated with greater side effects frequency, intensity, burden, and more serious adverse events during citalopram treatment",Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is mostly correct in conveying the relationship between depression and treatment response, but introduces additional details about side effects and citalopram specifically.",0.75
"Anxious depression Associated with greater side effect frequency, intensity, burden, and more serious adverse events compared to nonanxious depression",Depression Side effect Suicidal behavior,"Score: 0.75
The LLM output provides some relevant information about depression and side effects, but does not directly address the issue of suicidal behavior.",0.75
Anxious depression Associated with greater rate of side effects and serious adverse events compared to nonanxious depression,Depression Side effect Suicidal behavior,"Score: 0.75
The LLM output captured the theme of depression side effects and even mentioned the potential for serious adverse events, but did not specifically mention suicidal behavior as in the ground truth statement.",0.75
"Anxious depression Associated with low socioeconomic status, great severity of depression, late onset of depression, high physical illness burden, and significant clinical and sociodemographic differences","Depression-focused psychotherapy For Depression, psychosocial difficulties, interpersonal problems, and intra-psychic conflicts","Score: 0.50
The LLM output contains some relevant information about depression, but misses key aspects such as psychotherapy and specific psychosocial difficulties addressed in the ground truth.",0.5
